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Dedication: 
This article is dedicated to Professor David Smith, a dear friend and teacher of one of 
the authors (Claire Turner, CT).  CT has known David for 13 years and throughout 
that time he encouraged, helped and supported CT in developing her interest and 
breath analysis and VOC analysis. David’s attention to detail and uncompromising 
research ethic has enabled the development of SIFT-MS and without his leadership, 
the area of VOC and breath analysis would be much diminished.   
 
Abstract 
Monitoring blood glucose concentrations is a necessary but tedious task for people 
suffering from diabetes.  It has been noted that breath in people suffering with 
diabetes has a different odour and thus it may be possible to use breath analysis to 
monitor blood glucose concentration.  Here, we evaluate the analysis of breath using a 
portable device containing a single mixed metal oxide sensor during hypoglycaemic 
glucose clamps and compare that with the use of SIFT-MS described in previously 
published work on the same set of patients.  Outputs from both devices have been 
correlated with the concentration of blood glucose in 8 volunteers suffering from type 
1 diabetes mellitus.  The results demonstrate that acetone as measured by SIFT-MS, 
and the sensor output from the breath sensing device both correlate linearly with 
blood glucose, however the sensor response and acetone concentrations differ greatly 
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between patients with the same blood glucose. It is therefore unlikely that breath 
analysis can entirely replace blood glucose testing. 
Introduction: 
Diabetes mellitus is a complex disorder of metabolism which results in prolonged 
hyperglycaemia unless treated.  Treatment involves maintaining blood glucose 
concentrations within a tight range to maintain health using medication and diet, 
depending upon the type of diabetes (Kalapos, 2003).  However, in order to do this, 
blood glucose levels must be monitored frequently throughout each day (Evans et al., 
1999).  This requires taking a small blood sample for analysis using a portable 
glucose biosensor.  However, this deters many diabetes sufferers from monitoring 
their blood glucose, resulting in poor glycaemic control and the potential for serious 
complications. 
For this reason, there have been many efforts to develop easy, non-invasive, portable 
and unobtrusive methods of monitoring blood glucose, and many of these methods 
involve trying to find marker volatile organic compounds which may be present either 
in breath or from skin which are correlated with blood glucose (Turner, 2011, Wang 
and Wang, 2013).  An obvious candidate is acetone, which is abundant in breath, 
known to be elevated in diabetes and for which there are numerous analytical 
techniques. 
Another potential volatile biomarker is methyl nitrate (Novak et al., 2007), however, 
it is present at very low concentrations, which makes it unsuitable as a blood glucose 
surrogate due to the difficulties in producing a selective, specific and sensitive, 
portable, low cost and non-invasive monitoring device.  So for this reason, monitoring 
breath acetone is an ideal biomarker if indeed it does show a correlation with blood 
glucose (Turner, 2011, Wang and Wang, 2013).  There have been a number of recent 
studies to develop sensors for monitoring acetone in breath for this reason (Saraoğlu 
et al, 2013; Righettoni et al., 2013; Worrall et al., 2013, Deng et al., 2013). 
Techniques used for analysing volatile organic compounds (VOCs) in breath or from 
skin fall into two classes: developmental or research techniques, where the emphasis 
is on biomarker detection and quantification, and point of care monitoring devices.  In 
the first category falls mass spectrometric techniques, such as selective ion flow tube 
mass spectrometry (SIFT-MS) (Smith and Spanel, 2011) or PTR-MS (Beauchamp et 
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al., 2013), GC-MS (Grabowska-Polanowska, 2013) and other similar devices (Amann 
and Smith, 2013).  The second category must be made portable, inexpensive yet 
sufficiently selective for the VOC(s) of interest.  This generally includes devices 
which make use of gas sensors, including metal oxide sensors (Bârsan et al, 2003; 
Righettoni et al, 2010), conducting polymer sensors (Yu et al., 2005; Do et al, 2013), 
FET and MOSFET sensors and optical sensors (Ermanok et al., 2013)  and other  
types. (Zhang et al, 2000; Guo et al., 2010; Saraoglu et al., 2010).  Also possible is the 
development of specific optical sensors, and this technology is rapidly being 
developed to produce more sensitive and selective sensors for uses such as this with 
potentially much reduced response times (Wang et al, 2013). When gas sensors are 
used, they are often assembled into an array in which each sensor responds to 
different VOCs to a greater or lesser extent, building up a pattern rather than an 
individual signal for each sample. Such devices are often known as electronic noses 
(Gardiner and Bartlett, 1994).  These devices require some complex algorithms to 
process data from multiple sensors and carry out pattern recognition to compare to 
training data sets. In many cases, this is necessary but where a single analyte (e.g. 
acetone) is involved, this device is overly-complex . 
Here, we discuss the use of both a single metal oxide sensor breath analysis device 
and its comparison with acetone data obtained from SIFT-MS in the analysis of 
breath.  The study was conducted on a number of patients with type 1 diabetes 
mellitus and blood and breath samples were taken at different blood glucose 
concentrations in a hypoglycaemic glucose clamp study.   Analysis of acetone using 
SIFT-MS during this study has previously been reported (Turner et al., 2009). This 
enables the signal from a single sensor to be both assessed against identification and 
quantification of some of the volatile compounds present as well as against 
conventionally taken samples for determination of blood glucose. The single sensor 
greatly simplifies analysis, with no need for complex algorithms to carry out pattern 
recognition or perform multivariate statistics. 
The single metal oxide sensor gas analyser, SMOS-GA, is referred to in this 
manuscript as “The Breathotron”.   
 
Materials and Methods 
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The breath analysis device, the Breathotron 
The Breathotron is a mains-powered, field-portable instrument housed in a briefcase-
sized enclosure (Figure 1).  The sensing element is a low cost, single mixed metal 
oxide semiconductor (MMOS), using a proprietary formulation of chromium-titanium 
oxide as its responsive element (CAP25, City Technology Ltd, Portsmouth, UK).   
MMOS as a class are relatively unaffected by the water content of the sample 
compared with conducting polymer sensors for example, an important consideration 
in breath analysis (Bârsan et al, 2003).   
MMOS, in common with some other classes of gas sensor, have been reported to 
exhibit significant drift and poor reproducibility (Gardiner and Bartlett, 1994). In 
addition, they have a long response and recovery time compared to the duration of the 
human breath. A MMOS exposed to an atmosphere containing VOCs may take 
several minutes to reach full scale response, and a similar time to recover. The main 
consequence for the Breathotron design is that no attempt is made to use the full scale 
response; the sensor is exposed to the breath for a time much shorter than that 
required to attain full scale response by passing a known volume across it at a 
carefully controlled flow rate.  
The Breathotron was designed to allow samples to be taken from spontaneously 
breathing subjects, without the need for any particular manoeuvres to be learned and 
this was achieved by adapting an industrial filter mask (3M 7000S series, 3M United 
Kingdom plc, Bracknell, UK).   The silicone face seal minimises the probability of 
allergic reaction, covers the nose and mouth and is worn with a full head harness, 
allowing it to be adjusted to form a seal against the skin of the subject.  It incorporates 
non-return valves at the inlet and outlet and is controlled by a mass flow sensor 
(AWM720P, Honeywell International Inc., Morristown, NJ, USA) which measures 
exhaled breath flow rate. This is used to control the sampling sequence of the 
instrument. The device is operated via software on a Personal Digital Assistant (PDA) 
which connects to the Breathotron over a serial (RS-232) data link. 
Figure 2 shows the general layout of the pneumatic system and summarises the 
operation of the device.  In summary, the MMOS is continually flushed by purified air 
while not sampling breath.  While breath is sampled, the flow in the sampling arm is 
increased to typically 200 ml min
-1
, causing exhaled breath to be drawn into the 
sample loop. If the MMOS is not to be exposed to this breath, the flow in the 
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sampling arm is reduced to zero at the end of the breath and the instrument returns to 
standby mode.  
If the MMOS is to be exposed to this sample, the sample arm flow is switched off at 
the end of the breath and the crossover valves simultaneously switch. This causes the 
sample to be flushed out of the sample loop towards the MMOS by the incoming 
clean air stream. As the contents of the sample loop pass over the MMOS, the sample 
loop becomes filled with clean air from the flushing inlet. When this process is 
complete (typically 5-10s) the crossover valves switch back, returning the instrument 
to Standby. Using this arrangement the rates of filling and flushing the sample loop 
can differ while maintaining a constant flow rate across the MMOS at all times.  
The gas sensor is housed in a specially machined two-piece aluminium block 
consisting of a hollow sensor chamber with inlet and outlet sample ports and a flat 
closing plate with a nitrile gasket to provide a gas-tight seal. The sensor block is 
heated to prevent breath condensate from collecting inside the sensor chamber using a 
20 Watt Peltier thermoelectric heat pump fitted to the block’s flat closing plate. A 
controller circuit maintains block temperature at a nominal 40°C, although this can be 
set under software control if required. The top also carries a nitrile gasket and is 
sealed by a printed circuit board carrying the MMOS and preamplifier circuit. 
The preamplifier circuit allows the voltage and current in the MMOS to be 
determined, which are subsequently converted to sensor resistance in software. This 
signal is then normalised by subtracting the baseline resistance and presented as 
change in sensor resistance (ΔR) over time (Figure 3). Sensor response data are 
expressed as maximum excursion of ΔR (ΔRmax) following exposure of the MMOS to 
the sample. Sensor operating temperature was optimised for acetone using 10ppm 
acetone in synthetic air (SIP Analytical Ltd, Sandwich, Kent, UK). A series of 
exposures was carried out at temperatures ranging from 360⁰C to 440⁰C and the 
maximum sensor response was observed at 420⁰C.  
Studies were carried out to assess the relationship between sensor response and the 
vapour phase concentration of a number of different compounds to assess linear 
range. Acetone, ammonia and propanol were investigated using a concentration range 
of 0-10ppm (0.1, 0.5, 1, 2, 5 and 10 ppm). Gases were supplied as above in cylinders 
of certified concentration and diluted as necessary using synthetic air (BOC, Guilford, 
Surrey) delivered by a gas mixer. This was constructed in-house using two mass flow 
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controllers (Microflo, Pneucleus Technologies LLC, NH, USA). Flow rates of 
calibration gas (10 ppm acetone in air as above) and zero grade air were set manually 
with the aid of a flowmeter (CSI 6000, Cambridge Scientific Instruments, Cambridge, 
UK) to give the required concentrations. Test samples were produced in Nalophan®  
gas sampling bags and allowed to equilibrate at laboratory temperature (20 - 22⁰C) for 
a minimum of five minutes prior to sampling with the Breathotron.  
Insulin clamp details; glucose and insulin infusion.  
Full details of the recruitment of patients and the hypoglycaemic clamp study are 
given in Turner et al. (2009).  Briefly, 8 individuals with type 1 diabetes were 
recruited.  Each had a relatively long duration of diabetes (mean 28 + 3 years) and, on 
average sub-optimal glycaemic control. Volunteers were admitted to hospital 
overnight and an insulin clamp technique was used to control plasma glucose values 
throughout the course of the clamp study. Blood glucose levels were controlled at the 
appropriate concentration through a primed continuous infusion of regular insulin 
(Humulin S, 60 mU/kg/min) plus a variable infusion of 20% dextrose. Using this 
technique, the blood glucose concentration was reduced in 40 minute steps aiming for 
5, 3.8. 3.3, 2.8 and 2.4 mM respectively (the latter step was only 20 minutes).  
Taking breath samples  
Volunteers provided breath samples directly into the Breathotron and into Nalophan 
sample bags (Air Products UK Ltd) for later analysis by SIFT-MS at each time point 
(i.e at the baseline blood level at the start and at each glucose clamp step).  Thus 
breath samples were taken at 30 minutes into each of the 40 minute stages of the 
target blood glucose concentrations.  The final stage of the clamp nominally at 2.2mM 
blood glucose lasted for only 20 minutes due to the fact this was at too low a level to 
maintain for 40 minutes and breath samples were taken at the end of the stage.  The 
breath samples in the Nalophan bags were stored together in a black plastic bag and 
taken to the laboratory for analysis by SIFT-MS a few hours later.  It had previously 
been shown that there was little loss of acetone from Nalophan bags over this time 
period (Turner et al., 2012). 
Blood glucose analysis 
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Plasma glucose concentrations were measured at five minute intervals using a Yellow 
Springs Instruments (YSI) analyser to enable the exact concentration to be correlated 
with the time of each breath sample. 
 
SIFT-MS analysis 
SIFT-MS has been described in detail previously (Smith and Španěl, 2005) so only a 
brief summary is given here.  In SIFT-MS precursor ions  (H3O
+
, NO
+
 and O2
+
)  are 
produced from air and water vapour in a microwave discharge and are selected by a 
quadrupole mass filter.  They are then injected into a fast flowing helium carrier gas, 
reacting with the trace gases and volatile organic compounds in the breath sample..  
The precursor and product ions in the carrier gas pass into a second quadrupole mass 
spectrometer and detector for analysis.  Data may be obtained through scanning a 
spectrum at a user-defined range of m/z values or by sampling individual ions.  
Acetone reacts with all three precursor ions, and in this study, analysis of acetone was 
carried out using the both H3O
+
 and NO
+
 precursor ions (as described in Turner et al., 
2009) to provide additional checks on the data obtained.   
 
Results: 
Breathotron: Testing of the Breathotron with different concentrations of three 
common breath volatiles - acetone, ammonia and propanol, over the range (0 – 10 
ppmv) resulted in the responses (ΔRmax) of the MMOS which are shown in Figure 4.  
The sensor’s response to all three compounds was linear over the range investigated. 
The responses for acetone and propanol were of similar magnitude while that for 
ammonia, although also linear, was very much smaller.  In fact, ammonia barely 
caused a change in sensor resistance, so it is unlikely to be able to reliably detect 
ammonia in breath.  
SIFT-MS results in glucose clamp 
Results showing the relationship between breath acetone (as measured by SIFT-MS) 
and blood glucose in this clamp study for each of the 8 diabetics tested in this study 
are recorded in Turner et al. (2009) so will not be repeated here.  However, it is clear 
that although the acetone concentrations at each blood glucose concentration differ 
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greatly between each volunteer, the data for individual volunteers exhibits a linear 
decrease in breath acetone with as the blood glucose concentration is reduced.  Figure 
5 shows this for one volunteer in the glucose clamp study.  Propanol, which gives a 
similar magnitude MMOS signal to acetone was not detected in appreciable quantities 
in the breath samples taken. 
Breathotron results from glucose clamp 
Breathotron samples were obtained contemporaneously with those intended for 
analysis by SIFT-MS, and the ΔRmax values at each blood glucose concentration are 
shown in Figure 6.  As can be seen from these graphs, it is clear that there is a linear 
relationship between blood glucose concentration and ΔRmax response of the 
Breathotron for each of the 8 individuals throughout the glucose clamp and at 
different blood glucose concentrations, with the exception of subject e).  In 
comparison with those in Turner et al. (2009), all are similar except for e).  This 
implies that the signal from the Breathotron is not dependent upon acetone alone and 
that other VOCs may also be contributing to the signal, although analysis of the SIFT-
MS data did not indicate what this other compound could be; there was certainly not 
very much propanol present in the breath of these subjects during the clamp.  Despite 
this, for seven out of the eight subjects, there was a clear positive linear relationship 
between sensor signal and blood glucose.   
Figure 7 shows representative graphs of data from two volunteers of the Breathotron 
sensor response against breath acetone determined using SIFT-MS. Tests with the 
highest and lowest values of R
2
 have been selected for display and the case with the 
highest value (upper panel of Figure 7) corresponds to the results shown in Figure 5. 
While a positive trend is observed in all cases, it is clear that the strength of the 
association varies considerably between individual tests.  
 
Discussion: 
Here, we have demonstrated that a portable breath sensing device (The Breathotron) 
has been able to monitor the breath of subjects with type 1 diabetes in a 
hypoglycaemic glucose camp.  The signal from the Breathotron is correlated with 
acetone as measured by SIFT-MS (Figure 6), and also with blood glucose.  The 
correlation was positive for ΔRmax against blood glucose for seven out of eight 
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subjects in comparison with eight out of eight for the corresponding data from SIFT-
MS. In the one subject where the correlation between blood glucose and ΔRmax was 
negative, it indicates that acetone was not solely responsible for the entire MMOS 
signal.   
Although it has been shown that end-tidal breath samples are the most accurate in 
quantifying breath VOCs (King et al. 2009), acetone is well represented by whole 
breath and differences do not affect the results of this study. 
There were some differences in the acetone/Breathotron signal correlations for one 
subject. Here, the correlation between between glucose concentration and acetone 
determined by SIFT-MS was weakest out of all the volunteers. In fact the breath 
acetone concentration was around 600 ppbv at both the highest and lowest values of 
glucose recorded, with a nadir at around 400 ppbv in the mid-range.  This suggests 
that, at least to some degree, a real physiological phenomenon is being observed.  
Although this shows promise as a method for monitoring blood glucose, the 
relationship between blood glucose concentration and sensor response expressed as 
ΔRmax clearly differs quantitatively between individuals. However it remains possible 
that each individual will have a relationship which is specific to themselves (Turner et 
al., 2009; Turner et al., 2011).  If there are other compounds contributing to the 
observed correlations, sensor-based instruments such as the Breathotron are not 
themselves a suitable means of determining either their identity or abundance. 
Research into seeking compounds in breath that may be used to monitor blood 
glucose requires more sophisticated analytical equipment such as SIFT-MS which can 
directly speciate and determine volatile organic compounds found in breath. 
Despite this, portable breath analysis devices have the potential to be convenient, non-
invasive, robust and inexpensive compared with the lifetime cost of a blood glucose 
biosensor and associated glucose testing strips. Such devices seem unlikely to totally 
replace the need for blood glucose monitoring, but may be useful to warn of 
impending hyper- or hypo-glycaemic episodes or to enable increased sampling 
frequency giving better overall control of glycaemia. This may be of particular value 
for hypo-unaware sufferers for whom the consequences of a hypoglycaemic attack are 
potentially catastrophic.  
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Figure 2 
 General layout of the Breathotron pneumatic system, A-D showing the process of 
sample aspiration and delivery to the sensor. A – standby; B - aspiration; C and D - 
sensor exposure. MMOS – mixed-metal oxide semiconductor; MFC – mass flow 
controller. 
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Figure 3: Instrument responses to reference gas (1ppm acetone) and a sample of 
human breath. Both signals have been normalised to an initial value of zero value 
subtracting the mean baseline resistance.
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Figure 4.  Calibration curves for three volatile organic compounds typically found in 
human breath at physiologically representative concentrations. 
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Figure 5.  Results of glucose clamp for one subject showing breath acetone 
concentrations vs blood glucose 
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Figure 6. Individual Breathotron (MMOS) responses (ΔRmax) plotted against achieved 
glucose concentrations for eight hypoglycaemia-unaware volunteers (a-h) during a 
hypoglycaemic clamp.
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Figure 7.  Relationship between sensor response (ΔRmax) and breath acetone as 
determined by SIFT-MS in two example cases.  Individuals with the highest (upper 
panel) and lowest (lower panel) values of R
2
 have been selected.  
